Site Map | Contact Us

Learn more about implantable telescope technology and VisionCare clinical trials

The Implantable Miniature Telescope IMT™ (by Dr. Isaac Lipshitz) for macular degeneration.

April 24th Meeting of Ophthalmic Devices Advisory Panel Postponed

VisionCare Ophthalmic Technologies Announces Presentations on Implantable Telescope for End-Stage Macular Degeneration at ARVO Annual Meeting

VisionCare Ophthalmic Technologies Announces Presentations at the American Society of Cataract and Refractive Surgery Annual Meeting

Results of Implantable Telescope Trial Published in Ophthalmology Report on Vision and Quality of Life in Patients with End-Stage Age-Related Macular Degeneration

VisionCare Ophthalmic Technologies Announces Presentations at the Annual Meeting of the American Society of Cataract and Refractive Surgery

VisionCare Pivotal Study Shows Improved Vision and Quality of Life Outcomes in Patients with AMD

VisionCare Announces Presentations on Pivotal Trial Results at the American Academy of Ophthalmology Annual Meeting

VisionCare Appoints Joaquin Wolff Vice President of Global Marketing & Sales

VisionCare Relocates and Expands Facility in Israel

Michael J. Strauss, M.D., Joins VisionCare Board of Directors

VisionCare Closes $20 Million Series D Financing

Get the latest information on our clinical trials.

Caution: Investigational Device, Limited by Federal Law to Investigational Use.

The Implantable Miniature Telescope is referred to as "the IMT (by Dr. Isaac Lipshitz)" or as "the Implantable Miniature Telescope (by Dr. Isaac Lipshitz)." Hereinafter, this investigational device may be referred to "the product", "the device", "the telescope", or similar terms which cannot be read as the name of the product.